Low impact
Novo Nordisk raised its outlook but investors reacted negatively to pricing pressure, a pill sales miss, and a pipeline setback.
Finnhub08/05, 10:06 PM
Related assets
Coming up for NVO
Explore next
Latest NVO news
MarketWatch08/27, 03:37 PM
Deutsche Bank downgraded Novo Nordisk to sell after the stock fell 70% from its peak.
Jin1008/27, 10:33 AM
Novo Nordisk has applied for approval of an oral formulation of Wegovy for weight management.
Finnhub08/19, 05:10 PM